Novavax, Inc. (NVAX)
10.12
+0.75
(+8.00%)
USD |
NASDAQ |
Sep 01, 16:00
10.04
-0.08
(-0.79%)
After-Hours: 19:41
Novavax Total Long Term Debt (Quarterly) : 297.32M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 297.32M |
| March 31, 2026 | 295.06M |
| December 31, 2025 | 268.17M |
| September 30, 2025 | 251.14M |
| June 30, 2025 | 228.49M |
| March 31, 2025 | 228.66M |
| December 31, 2024 | 253.38M |
| September 30, 2024 | 233.31M |
| June 30, 2024 | 233.24M |
| March 31, 2024 | 229.33M |
| December 31, 2023 | 257.66M |
| September 30, 2023 | 222.11M |
| June 30, 2023 | 198.94M |
| March 31, 2023 | 199.06M |
| December 31, 2022 | 599.87M |
| September 30, 2022 | 438.09M |
| June 30, 2022 | 448.43M |
| March 31, 2022 | 440.50M |
| December 31, 2021 | 493.11M |
| September 30, 2021 | 427.09M |
| June 30, 2021 | 430.32M |
| March 31, 2021 | 460.23M |
| December 31, 2020 | 478.10M |
| September 30, 2020 | 440.64M |
| June 30, 2020 | 321.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 320.97M |
| December 31, 2019 | 330.62M |
| September 30, 2019 | 330.50M |
| June 30, 2019 | 330.58M |
| March 31, 2019 | 336.94M |
| December 31, 2018 | 319.19M |
| September 30, 2018 | 318.83M |
| June 30, 2018 | 318.48M |
| March 31, 2018 | 318.12M |
| December 31, 2017 | 317.76M |
| September 30, 2017 | 317.41M |
| June 30, 2017 | 317.05M |
| March 31, 2017 | 316.70M |
| December 31, 2016 | 316.34M |
| September 30, 2016 | 316.03M |
| June 30, 2016 | 315.78M |
| March 31, 2016 | 315.52M |
| December 31, 2015 | 0.395M |
| September 30, 2015 | 0.538M |
| June 30, 2015 | 0.681M |
| March 31, 2015 | 0.831M |
| December 31, 2014 | 0.998M |
| September 30, 2014 | 1.605M |
| June 30, 2014 | 1.808M |
| March 31, 2014 | 2.009M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Moderna, Inc. | 1.266B |
| Merck & Co., Inc. | 51.08B |
| Pfizer Inc. | 63.10B |
| Recursion Pharmaceuticals, Inc. | 53.39M |
| Agenus, Inc. | 259.00M |